Anticancer agent 189
Anticancer agent 189 (compound 4) is an anticancer agent that antagonizes CRC effects by targeting AKT1[1].
Product Specifications
CAS Number
[9007-83-4]
UNSPSC
12352005
Target
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-189.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(O[C@@H]([C@@H](/C=C/C=C([C@H](OC)C[C@H](O1)[C@]1(C)C(N([C@H]2[C@](CC)(C)[H])C)=O)\C)C)C3=CC=CC=C3)=O)C(C)(O)C)[C@H](NC2=O)CC4=CC=C([N+]([O-])=O)C=C4
Molecular Formula
C42H56N4O10
Molecular Weight
776.91
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1352506-01 0.02 mg (E-Coli)
Recombinant Bartonella quintana Dihydrodipicolinate reductase (dapB)
Ask
View Details